Todd Cumbie, MD
Vascular Surgery · Texarkana, TXNPI 1679777585
Payments from drug & device makers
Across 99 payments — averaging $69.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$3K
- Silk Road Medical, Inc.$1K
- W. L. Gore & Associates, Inc.$864
- Boston Scientific$364
- Penumbra, Inc.$302
- Philips North America LLC$268
- plus $905 from 17 others
What the payments were for
- Travel & lodging$79212%
- Food & beverage$6,06988%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 12 | $2,901 |
| Silk Road Medical, Inc. | 14 | $1,257 |
| W. L. Gore & Associates, Inc. | 20 | $864 |
| Boston Scientific | 12 | $364 |
| Penumbra, Inc. | 3 | $302 |
| Philips North America LLC | 4 | $268 |
| Johnson & Johnson | 12 | $264 |
| Angiodynamics, Inc. | 5 | $260 |
| Smith+Nephew | 1 | $98 |
| Baxter Healthcare | 2 | $36 |
| Cook Medical LLC | 1 | $29 |
| Tactile Systems Technology Inc | 2 | $26 |
| Bard Peripheral Vascular, Inc. | 1 | $25 |
| Cardiovascular Systems Inc. | 1 | $22 |
| Shockwave Medical, Inc | 1 | $21 |
| Triad Life Sciences Inc. | 1 | $21 |
| Chiesi USA, Inc. | 1 | $20 |
| Thrombolex, Inc. | 1 | $18 |
| Cardiva Medical, Inc. | 1 | $14 |
| EKOS Corporation | 1 | $14 |
| Teleflex LLC | 1 | $13 |
| Getinge USA Sales, LLC | 1 | $12 |
| Bolton Medical Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AFX$1,062
- ENROUTE Transcarotid Neuroprotection System$893
- ENROUTE Transcarotid Stent System$893
- ENHANCE Transcarotid Peripheral Access Kit$893
- ENROUTE 0.014 Guidewire$893
- Ovation$816
- Ovation iX Iliac Stent Graft$621
- Alto Abdominal Stent Graft System$464
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$240
- AFX2 Bifurcated Endograft System$220
- Penumbra System$162
- C3 Delivery System$118
- Turbo Elite$118
- GORE TAG Conformable Thoracic Endoprosthesis$105
- Conformable TAG Thoracic Endoprosthesis$104
How this compares
$6,861 in reported general payments places this provider in the 45th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 30 | $21,681 |
| XareltoRivaroxaban | 20 | $21,114 |
| ClopidogrelClopidogrel Bisulfate | 160 | $1,735 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 83 | $377 |
| Rosuvastatin Calcium | 21 | $185 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 19 | $42 |
| Tramadol Hcl | 11 | $34 |
| Diazepam | 13 | $25 |
| Prednisone | 14 | $19 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $264 | $21,11420 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 347 vascular surgery providers in Texas.
Other vascular surgery in Texarkana
- Mazin FotehAustin$2.5M
- Alan LumsdenHouston$2.4M
- Gregory PearlDallas$2.3M
- Gustavo OderichHouston$999K
- Michael SiahDallas$838K
- Stephen HohmannDallas$587K
- Dennis GableDallas$547K
- Carlos TimaranDallas$527K
- Samuel LeonardHouston$431K
- Ali AzizzadehHouston$387K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.